HAE Haemonetics Corporation Common Stock
$107,00
Prezzo · Ago 19, 2026
Fondamentali al Ago 6, 2026
Intervallo 52 sett.
$47–$107
99% of range
Rating Analisti
BUY
15 analysts
Prezzo Obiettivo
$99
P/E (TTM)
52.2
ROE
11.8%
Margine di Profitto Netto
7.3%
Informazioni su Haemonetics Corporation Common Stock Panoramica della società da Wikipedia
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Leggi di più
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
History
The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.
In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.
Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.
In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.
Product categories
Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.
Hemostasis
TEG 5000
Kaolin TEG
Kaolin TEG with Heparinase
RapidTEG
TEG Functional Fibrinogen
TEG PlateletMapping
TEG 6S
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
HAE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$107.00
Capitalizzazione di Mercato
$4.84B
P/E (TTM)
52.2
EPS (TTM)
$2.05
Ricavi (TTM)
$1.33B
Rendimento div.
—
ROE
11.8%
D/E Debito/Patrimonio
1.5
Intervallo 52 sett.
$47 – $107
HAE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$1.33B
2017-04-01
→
2026-03-28
EPS
$2.05
2017-04-01
→
2026-03-28
Flusso di cassa libero
$260M
2017-04-01
→
2026-03-28
Margini
7.3%
2017-04-01
→
2026-03-28
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
HAE
Mediana dei peer
P/E (TTM)
52.2
39.4
P/S (TTM)
3.6
2.1
P/B
6.1
3.3
EV / EBITDA
37.1
—
Price / FCF (Prezzo / FCF)
18.6
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
HAE
Mediana dei peer
Gross Margin (Margine lordo)
59.0%
58.7%
Operating Margin (Margine Operativo)
11.8%
—
Net Profit Margin (Margine di Profitto Netto)
7.3%
-11.8%
ROA
4.0%
-6.3%
ROE
11.8%
-13.4%
ROIC
5.9%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
HAE
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
1.5
37.4
Current Ratio (Rapporto corrente)
3.0
2.4
Quick Ratio
1.6
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
HAE
Mediana dei peer
Revenue YoY (Ricavi YoY)
-2.0%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
4.5%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
8.9%
—
EPS YoY
-38.1%
—
Net Income YoY (Utile Netto YoY)
-42.0%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
HAE
Mediana dei peer
HAE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
15 analisti
- Acquisto forte 5 33,3%
- Compra 6 40,0%
- Mantieni 4 26,7%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
10 analisti · 2026-08-20
Mediana
$96.00
Media
$98.90
Ora
$107.00
Basso
$86.00
Alto
$120.00
Target mediano
$96.00
-10,3%
Target medio
$98.90
-7,6%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.06%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2027 | $1.14 | $1.09 | 0.05% |
| 30 Giugno 2026 | $1.14 | $1.09 | 0.05% |
| 31 Marzo 2026 | $1.29 | $1.28 | 0.01% |
| 31 Dicembre 2025 | $1.31 | $1.26 | 0.05% |
| 30 Settembre 2025 | $1.27 | $1.12 | 0.15% |
| 30 Giugno 2025 | $1.10 | $1.03 | 0.07% |
| 31 Marzo 2025 | $1.24 | $1.23 | 0.01% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
Stato Patrimoniale 25
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
Flusso di cassa 16
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
Redditività 8
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
Efficienza 3
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
Tassi di Crescita 9
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
Conto Economico 16
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
Stato Patrimoniale 25
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
Flusso di cassa 13
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
Redditività 8
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
Efficienza 3
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
Valutazione (TTM) 14
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Ricavi | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| Margine Lordo % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Margine Operativo % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| Utile netto | $97M | $168M | $118M | $115M | $43M |
| EPS Diluito | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
Stato Patrimoniale
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| Rapporto corrente | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
Flusso di cassa
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $260M | $142M | $115M | $163M | $76M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 363 filer · $2.6B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 62 (+3 vs trimestre precedente) | 43 (-12 vs trimestre precedente) | 108 (-5 vs trimestre precedente) | 112 (-3 vs trimestre precedente) | +1.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349.945.961 | 4.366.138 | 13,44% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $308.172.249 | 4.108.761 | 11,84% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190.979.550 | 2.546.394 | 7,34% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $154.468.350 | 2.059.578 | 5,93% | Azioni |
| STATE STREET CORP | $136.363.950 | 1.818.186 | 5,24% | Azioni |
| CITADEL ADVISORS LLC | $113.259.000 | 1.510.120 | 4,35% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $109.143.975 | 1.455.253 | 4,19% | Azioni |
| River Road Asset Management, LLC | $96.420.150 | 1.285.602 | 3,70% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86.651.325 | 1.155.351 | 3,33% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $79.315.930 | 1.057.321 | 3,05% | Azioni |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62.319.375 | 830.925 | 2,39% | Azioni |
| GOLDMAN SACHS GROUP INC | $52.644.150 | 701.922 | 2,02% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44.356.725 | 591.423 | 1,70% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $42.780.975 | 570.413 | 1,64% | Azioni |
| Holocene Advisors, LP | $41.264.625 | 550.195 | 1,58% | Azioni |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37.034.909 | 493.796 | 1,42% | Azioni |
| North Peak Capital Management, LLC | $25.730.775 | 343.077 | 0,99% | Azioni |
| LONDON CO OF VIRGINIA | $25.543.299 | 340.574 | 0,98% | Azioni |
| DEUTSCHE BANK AG\ | $25.282.575 | 337.101 | 0,97% | Azioni |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24.905.625 | 332.075 | 0,96% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $24.779.850 | 330.398 | 0,95% | Azioni |
| Boston Trust Walden Corp | $24.170.475 | 322.273 | 0,93% | Azioni |
| Aristotle Capital Boston, LLC | $21.721.809 | 289.624 | 0,83% | Azioni |
| MIZUHO MARKETS AMERICAS LLC | $21.166.050 | 282.214 | 0,81% | Azioni |
| BANK OF AMERICA CORP /DE/ | $20.122.875 | 268.305 | 0,77% | Azioni |
| Invenomic Capital Management LP | $16.216.275 | 216.217 | 0,62% | Azioni |
| FMR LLC | $15.638.325 | 208.511 | 0,60% | Azioni |
| HEARTLAND ADVISORS INC | $15.000.000 | 200.000 | 0,58% | Azioni |
| GLENMEDE TRUST CO NA | $14.454.000 | 192.720 | 0,56% | Azioni |
| MORGAN STANLEY | $13.073.475 | 174.313 | 0,50% | Azioni |
| Longaeva Partners L.P. | $12.286.650 | 163.822 | 0,47% | Azioni |
| RHUMBLINE ADVISERS | $10.812.225 | 144.163 | 0,42% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $10.613.250 | 141.510 | 0,41% | Azioni |
| Balyasny Asset Management L.P. | $10.123.575 | 134.981 | 0,39% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $9.750.000 | 130.000 | 0,37% | Azioni |
| Point72 Asset Management, L.P. | $8.192.700 | 109.236 | 0,31% | Azioni |
| Verition Fund Management LLC | $7.913.100 | 105.508 | 0,30% | Azioni |
| ARIEL INVESTMENTS, LLC | $7.569.975 | 100.933 | 0,29% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $7.500.000 | 100.000 | 0,29% | Opzione Call |
| KESTREL INVESTMENT MANAGEMENT CORP | $7.305.000 | 97.400 | 0,28% | Azioni |
| Divisadero Street Capital Management, LP | $7.234.425 | 96.459 | 0,28% | Azioni |
| Swiss National Bank | $6.997.500 | 93.300 | 0,27% | Azioni |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Opzione Call |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Opzione Put |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.510.000 | 86.800 | 0,25% | Opzione Call |
| Squarepoint Ops LLC | $6.459.300 | 86.124 | 0,25% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $6.215.025 | 82.867 | 0,24% | Azioni |
| Quantinno Capital Management LP | $5.477.550 | 73.034 | 0,21% | Azioni |
| ROYCE & ASSOCIATES LP | $5.360.625 | 71.475 | 0,21% | Azioni |
| AMERIPRISE FINANCIAL INC | $5.358.525 | 71.447 | 0,21% | Azioni |
| JUPITER ASSET MANAGEMENT LTD | $5.229.300 | 69.724 | 0,20% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $5.166.634 | 91.672 | 0,20% | Azioni |
| SEGALL BRYANT & HAMILL, LLC | $5.106.900 | 68.092 | 0,20% | Azioni |
| AMERICAN CAPITAL MANAGEMENT INC | $5.018.625 | 66.915 | 0,19% | Azioni |
| ISTHMUS PARTNERS, LLC | $4.946.325 | 65.951 | 0,19% | Azioni |
| Corient Private Wealth LP | $4.851.975 | 64.693 | 0,19% | Azioni |
| FIRST TRUST ADVISORS LP | $4.751.850 | 63.358 | 0,18% | Azioni |
| DEAN INVESTMENT ASSOCIATES, LLC | $4.649.175 | 61.989 | 0,18% | Azioni |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4.497.450 | 59.966 | 0,17% | Azioni |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4.484.325 | 59.791 | 0,17% | Azioni |
| Bridgewater Associates, LP | $4.479.975 | 59.733 | 0,17% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $4.181.475 | 55.753 | 0,16% | Azioni |
| Trexquant Investment LP | $3.946.425 | 52.619 | 0,15% | Azioni |
| Aequim Alternative Investments LP | $3.840.000 | 51.200 | 0,15% | Azioni |
| RICE HALL JAMES & ASSOCIATES, LLC | $3.827.850 | 51.038 | 0,15% | Azioni |
| JANE STREET GROUP, LLC | $3.682.500 | 49.100 | 0,14% | Opzione Call |
| MetLife Investment Management, LLC | $3.681.075 | 49.081 | 0,14% | Azioni |
| BlackRock, Inc. | $3.618.975 | 48.253 | 0,14% | Azioni |
| Retirement Systems of Alabama | $3.604.875 | 48.065 | 0,14% | Azioni |
| Riverwater Partners LLC | $3.573.375 | 47.645 | 0,14% | Azioni |
| Skylands Capital, LLC | $3.571.875 | 47.625 | 0,14% | Azioni |
| FIFTH THIRD BANCORP | $3.561.472 | 47.486 | 0,14% | Azioni |
| ALGERT GLOBAL LLC | $3.522.750 | 46.970 | 0,14% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.441.750 | 45.890 | 0,13% | Azioni |
| Qube Research & Technologies Ltd | $3.425.475 | 45.673 | 0,13% | Azioni |
| Dean Capital Management | $3.372.600 | 44.968 | 0,13% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.351.375 | 44.685 | 0,13% | Azioni |
| EASTERLY INVESTMENT PARTNERS LLC | $3.248.025 | 43.307 | 0,12% | Azioni |
| Phocas Financial Corp. | $3.227.250 | 43.030 | 0,12% | Azioni |
| ZB,N.A. | $3.200.968 | 40.996 | 0,12% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3.190.200 | 42.536 | 0,12% | Azioni |
| CONNORS INVESTOR SERVICES INC | $3.150.000 | 42.000 | 0,12% | Azioni |
| Expect Equity LLC | $3.076.950 | 41.026 | 0,12% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.964.874 | 52.606 | 0,11% | Azioni |
| BEACON INVESTMENT ADVISORS LLC | $2.783.648 | 37.115 | 0,11% | Azioni |
| Campbell & CO Investment Adviser LLC | $2.763.300 | 36.844 | 0,11% | Azioni |
| Assenagon Asset Management S.A. | $2.633.175 | 35.109 | 0,10% | Azioni |
| BARCLAYS PLC | $2.448.300 | 32.644 | 0,09% | Azioni |
| MARSHALL WACE, LLP | $2.286.975 | 30.493 | 0,09% | Azioni |
| Cubist Systematic Strategies, LLC | $2.219.702 | 45.541 | 0,09% | Azioni |
| XTX Topco Ltd | $2.208.150 | 29.442 | 0,08% | Azioni |
| Legal & General Group Plc | $2.032.875 | 27.105 | 0,08% | Azioni |
| CARY STREET PARTNERS FINANCIAL LLC | $1.999.800 | 26.664 | 0,08% | Azioni |
| Nierenberg Investment Management Company, LLC | $1.971.000 | 26.280 | 0,08% | Azioni |
| Aurora Investment Counsel | $1.912.575 | 25.501 | 0,07% | Azioni |
| WESBANCO BANK INC | $1.912.500 | 25.500 | 0,07% | Azioni |
| Cardinal Capital Management | $1.861.275 | 24.817 | 0,07% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.846.275 | 24.617 | 0,07% | Azioni |
| Legato Capital Management LLC | $1.758.750 | 23.450 | 0,07% | Azioni |
| CITADEL ADVISORS LLC | $1.740.000 | 23.200 | 0,07% | Opzione Call |
Insider aziendali 72 insider · 48 dirigenti · 25 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 15 Maggio 2026 A | 444.704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 15 Settembre 2015 M | 147.040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 15 Maggio 2026 A | 54.444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 23 Agosto 2021 M | 30.291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 13 Gennaio 2016 A | 56.743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 01 Novembre 2006 P | 2.101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 26 Luglio 2024 S | 18.196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 25 Ottobre 2016 A | 23.318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 06 Luglio 2015 M | 34.102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 11 Novembre 2013 M | 10.987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 03 Maggio 2012 M | 4.442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 08 Agosto 2008 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 01 Maggio 2008 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 28 Novembre 2007 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 14 Giugno 2007 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 01 Novembre 2006 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 02 Maggio 2005 P | 2.347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 15 Maggio 2026 A | 32.936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 23 Ottobre 2015 S | 16.891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 05 Giugno 2026 F | 6.242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 05 Giugno 2026 F | 40.987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 15 Maggio 2026 A | 39.882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 15 Maggio 2026 A | 68.829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 12 Luglio 2024 S | 21.331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 28 Maggio 2024 F | 30.940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 13 Giugno 2022 S | 4.447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 07 Giugno 2021 S | 4.216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 11 Novembre 2019 S | 1.977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 07 Giugno 2018 S | 15.226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 25 Ottobre 2016 A | 16.867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 25 Ottobre 2016 A | 48.166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 26 Ottobre 2015 S | 30.507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 26 Ottobre 2015 S | 20.464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 23 Ottobre 2015 S | 16.235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 13 Aprile 2015 D | 13.216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 28 Agosto 2014 S | 5.013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 24 Luglio 2013 A | 7.618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 30 Aprile 2013 P | 17.279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 04 Maggio 2011 P | 3.052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 05 Aprile 2011 D | 2.815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 04 Novembre 2010 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 29 Luglio 2010 A | 10.580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 01 Maggio 2009 P | 15.849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 01 Maggio 2008 P | 1.041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 01 Maggio 2008 P | 12.188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 01 Maggio 2008 P | 4.891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 01 Maggio 2008 P | 3.024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 04 Maggio 2007 M | 4.193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | Direttore | 24 Luglio 2026 A | 15.471 | 0 | 0 | $0 |
| Diane M Bryant | Direttore | 24 Luglio 2026 A | 9.664 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 8 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 06 Febbraio 2004 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 20 Agosto 2003 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 08 Agosto 2003 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 24 Giugno 2003 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 19 Giugno 2003 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 03 Giugno 2003 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 27 Maggio 2003 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 15 Giugno 2001 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 88 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1,86% | 61.981 NS | 31 Maggio 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,84% | 43.927 NS | 30 Aprile 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,77% | 125.093 NS | 30 Aprile 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,64% | 5.836 NS | 30 Aprile 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,46% | 12.701 NS | 31 Maggio 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,36% | 110.180 NS | 30 Giugno 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,35% | 201.070 NS | 30 Aprile 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,32% | 35.814 NS | 31 Maggio 2026 | N-PORT |
| ABCS · EA Series Trust | 0,31% | 522 NS | 29 Maggio 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,24% | 41.437 NS | 30 Aprile 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,19% | 76.694 NS | 31 Maggio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 17.393 NS | 30 Aprile 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0,13% | 63 NS | 29 Maggio 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,13% | 1.703 NS | 30 Aprile 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 12.097 NS | 30 Aprile 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,12% | 2.419 NS | 30 Aprile 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,11% | 23.551 NS | 30 Aprile 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 42.163 NS | 30 Aprile 2026 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 126.817 NS | 31 Maggio 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,09% | 168 NS | 30 Aprile 2026 | N-PORT |
| RSSL · Global X Funds | 0,09% | 20.324 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,08% | 2.210 NS | 31 Maggio 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,08% | 5.212 NS | 30 Aprile 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,07% | 159.737 NS | 30 Aprile 2026 | N-PORT |
| MVV · ProShares Trust | 0,07% | 1.606 NS | 31 Maggio 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 222.776 NS | 31 Maggio 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 12.283 NS | 30 Aprile 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,06% | 770 NS | 30 Aprile 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,05% | 2.220 NS | 31 Maggio 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 1.979 NS | 31 Maggio 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,05% | 3.866 NS | 30 Aprile 2026 | N-PORT |
| UMDD · ProShares Trust | 0,05% | 224 NS | 31 Maggio 2026 | N-PORT |
| UWM · ProShares Trust | 0,05% | 1.729 NS | 31 Maggio 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,05% | 105.201 NS | 30 Aprile 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 21.461 NS | 30 Aprile 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 5.317 NS | 31 Maggio 2026 | N-PORT |
| URTY · ProShares Trust | 0,03% | 1.750 NS | 31 Maggio 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,03% | 2.270 NS | 31 Maggio 2026 | N-PORT |
| EBI · RBB Fund Trust | 0,03% | 2.598 NS | 31 Maggio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,03% | 8.470 NS | 30 Aprile 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,02% | 44.580 NS | 31 Maggio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 1.323 NS | 30 Aprile 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,02% | 40.040 NS | 30 Aprile 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 44 NS | 31 Maggio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 6.668 NS | 30 Aprile 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 97.492 NS | 30 Aprile 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 2.539 NS | 30 Aprile 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 1.282 NS | 31 Maggio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 11.534 NS | 30 Aprile 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 14.005 NS | 30 Aprile 2026 | N-PORT |